LMNX Share Price

Open 19.71 Change Price %
High 20.01 1 Day 0.26 1.32
Low 19.71 1 Week -0.83 -4.00
Close 19.91 1 Month -0.55 -2.69
Volume 170013 1 Year 0.83 4.35
52 Week High 23.75
52 Week Low 17.29
LMNX Important Levels
Resistance 2 20.19
Resistance 1 20.07
Pivot 19.88
Support 1 19.75
Support 2 19.63
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Luminex Corporation (NASDAQ: LMNX)

LMNX Technical Analysis 3
As on 20th Jan 2017 LMNX Share Price closed @ 19.91 and we RECOMMEND Sell for LONG-TERM with Stoploss of 20.62 & Sell for SHORT-TERM with Stoploss of 20.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
LMNX Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
LMNX Other Details
Segment EQ
Market Capital 700786944.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.luminexcorp.com
LMNX Address
LMNX
12212 Technology Boulevard
Austin, TX 78727
United States
Phone: 512-219-8020
Fax: 512-219-5195
LMNX Latest News
Luminex Corporation 10.2% Potential Decrease Now Implied by Deutsche Bank   DirectorsTalk Interviews   - 19th Jan 17
Luminex Corporation (LMNX) Given "Sell" Rating at Deutsche Bank AG   Sports Perspectives   - 18th Jan 17
Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 ...   PR Newswire (press release)   - 09th Jan 17
Luminex Corporation Receives FDA Clearance for ARIES® GBS Assay   PR Newswire (press release)   - 04th Jan 17
Luminex Corporation Reports Third Quarter 2016 Results; Raises Full Year Guidance   PR Newswire (press release)   - 01st Nov 16
Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus ...   PR Newswire (press release)   - 08th Aug 16
Luminex Corporation Receives FDA Clearance for New Molecular Test for ...   PR Newswire (press release)   - 03rd Aug 16
Luminex Corporation Completes Acquisition of Nanosphere, Inc.   PR Newswire (press release)   - 30th Jun 16
Luminex Corporation Announces Commencement of Tender Offer for All Outstanding ...   PR Newswire (press release)   - 02nd Jun 16
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.   PR Newswire (press release)   - 16th May 16
Interactive Technical Analysis Chart Luminex Corporation ( LMNX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Luminex Corporation
LMNX Business Profile
Luminex Corporation (Luminex)develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The Company�s Multi-Analyte Profiling (xMAP) technology, an open architecture, multiplexing technology, allows simultaneous analysis of up to 500 bioassays from a small sample volume, a single drop of fluid, by reading biological tests on the surface of microscopic polystyrene beads called microspheres. xMAP technology combines this miniaturized liquid array bioassay capability with small lasers, digital signal processors and software. Its xMAP technology is being used within various segments of the life sciences industry, which includes the fields of drug discovery and development, and for clinical diagnostics, genetic analysis, bio-defense, food safety and biomedical research. On June 27, 2011, the Company completed its acquisition of 100% interest of EraGen Biosciences, Inc.